Its just helping your body not hit that crash point where everything feels gross
In the head-to-head trial, liraglutide actually had a higher discontinuation rate due to side effects (27.6% vs 13.5%)
Among all treatment groups, mice treated with 10 nM [D-Ala2]-GIP showed no significant differences from the HFD group across all measured circulating biochemical parameters
Potential Benefits of GLP-1 Agonists Side Effects of GLP-1 Agonists Next Steps: Taking Action with GLP-1 Therapies Conclusion GLP-1, or Glucagon-like Peptide-1, is transforming the way we approach metabolic health
Tirzepatide works by: Activating GLP-1 receptors (same appetite reduction as semaglutide) Activating GIP receptors (additional metabolic benefits, including improved fat metabolism) Slowing stomach emptying and improving insulin sensitivity In the SURMOUNT-1 trial, participants on the highest dose of tirzepatide (15mg) lost an average of 22.5% of their body weight over 72 weeks - significantly more than semaglutide in comparable studies
The other three are unannounced GPCR targets